KNE Insider Trading
Insider Ownership Percentage: 37.21%
Insider Buying (Last 12 Months): C$79,800.00
Insider Selling (Last 12 Months): C$260,000.00
Kane Biotech Insider Trading History Chart
This chart shows the insider buying and selling history at Kane Biotech by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Kane Biotech Share Price & Price History
Current Price: C$0.10
Price Change: +0.30 (1.20%)
As of 01/17/2025 12:12 PM ET
Kane Biotech Insider Trading History
SEC Filings (Institutional Ownership Changes) for Kane Biotech (CVE:KNE)
Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections. It offers revyve, an antimicrobial wound gel; and shampoos, shampoo bars, and scalp detoxifiers under the DermaKB brand. The company is also developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; coactiv+ Antimicrobial Wound Rinse for use in acute and chronic wounds; coactiv+ Antimicrobial Wound Gel Spray for use in acute, chronic wounds, and first and second degree burns; and DispersinB Hydrogel for prosthetic joint infection. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
Read More on Kane Biotech
Today's Range
Now: C$0.10
52 Week Range
Now: C$0.10
Volume
2,500 shs
Average Volume
91,315 shs
Market Capitalization
C$13.25 million
P/E Ratio
N/A
Dividend Yield
3.08%
Beta
0.52
Who are the company insiders with the largest holdings of Kane Biotech?